Literature DB >> 26917806

Off-Label Drug Use: Whose Interests Are Served?

Alain Braillon, Joel Lexchin.   

Abstract

Mesh：

Year:  2016        PMID： 26917806     DOI： 10.1177/1062860616631822

Source DB:  PubMed          Journal:  Am J Med Qual        ISSN： 1062-8606            Impact factor:   1.852


× No keyword cloud information.
  4 in total

1.  Comment on: "Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France".

Authors:  Alain Braillon
Journal:  Drug Saf       Date:  2017-04       Impact factor: 5.606

2.  Comment on: "Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence".

Authors:  Alain Braillon
Journal:  Drug Saf       Date:  2016-11       Impact factor: 5.606

3.  Commentary: Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA.

Authors:  Xiulu Ruan; Jin Jun Luo; Alan David Kaye
Journal:  Front Psychiatry       Date:  2017-01-13       Impact factor: 4.157

Review 4.  Value-Based Health Care Delivery, Preventive Medicine and the Medicalization of Public Health.

Authors:  Andreas Vilhelmsson
Journal:  Cureus       Date:  2017-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.